Mirum Pharmaceuticals Cash Flow Statement 2018-2024 | MIRM

Fifteen years of historical annual cash flow statements for Mirum Pharmaceuticals (MIRM).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-163.42$-135.67$-83.99$-103.27$-52.55$-17.35
$11.95$3.24$0.60$0.62$0.00$0
$103$33.34$-66.35$12.96$6.07$14.54
$115$36.58$-65.75$13.58$6.07$14.54
$-43.97$-20.73$0$0$0$0
$-4.39$-3.45$-0.50$0$0$0
$0$0$0$0$0$0
$-5.05$-4.51$-5.18$-3.07$-2.94$-0.01
$-22.64$-21.05$16.98$0.61$7.12$2.44
$-70.94$-120.14$-132.76$-89.08$-39.36$-0.37
$-0.11$-0.28$-0.02$-0.23$-0.28$-7.50
$-20.00$0$-19.00$0$0$0
$-212.76$0$0$0$0$0
$126$7.98$-40.43$38.10$-127.50$0.00
$0$0$0$0$0$0
$126$7.98$-40.43$38.10$-127.50$0
$0$0$108$0$0$0
$-107.20$7.70$48.55$37.87$-127.78$-7.50
$305$0$0$0$0$0.05
$0$0$0$0$0$0
$305$0$0$0$0$0.05
$227$115$9.01$132$67.20$0.00
$227$115$9.01$132$127$59.79
$0$0$0$0$0$0
$-195.86$-5.55$64.45$49.42$0$0
$337$109$73.47$181$127$59.84
$158$-3.34$-10.75$130$-39.99$51.96
$35.02$27.01$23.09$12.55$6.07$0.03
$0$0$0$0$0$0